Top

Published in:

01-10-2023 | SCLC | Clinical study

Chemotherapy + ICIs in extensive-stage small-cell lung cancer: risk of interstitial lung disease

Published in: Reactions Weekly | Issue 1/2023

Excerpt

The incidence of drug-induced interstitial lung disease (D-ILD) in patients who received chemotherapy in combination with immune-checkpoint inhibitors (chemo-ICI) for extensive-stage small-cell lung cancer (ES-SCLC) may be higher in clinical practice than in clinical trials. …

Fukuda K, et al. Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer. Heliyon : 26 Sep 2023. Available from: URL: https://doi.org/10.1016/j.heliyon.2023.e20463

Title: Chemotherapy + ICIs in extensive-stage small-cell lung cancer: risk of interstitial lung disease
Publication date: 01-10-2023
Publisher: Springer International Publishing
Keywords: SCLC
SCLC
Cytostatic Therapy
Lung Cancer
Lung Cancer
Lung Cancer
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-48197-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Chemotherapy + ICIs in extensive-stage small-cell lung cancer: risk of interstitial lung disease

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Antineoplastics/immune globulin

Mycophenolate-mofetil

Antineoplastics

Doxorubicin

Tozinameran

Fremanezumab